PuraPharm Corporation Limited (1498) Announces Board Composition and Committee Roles

Bulletin Express

Oct 31

PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent non-executive members.

The Board is led by Chairman and Executive Director, Mr. Chan Yu Ling, Abraham. Other Executive Directors include Ms. Man Yee Wai, Viola and Dr. Tsoi Kam Biu, Alvin. The non-executive directors are Mr. Leung Stephen Kwok Keung and Mr. Dong Zimeng, and the independent non-executive directors are Dr. Hung Ting On, John, Dr. Leung Lim Kin, Simon, and Prof. Tsui Lap Chee.

According to the announcement, the Audit Committee is chaired by Dr. Hung and includes Dr. Leung and Prof. Tsui. The Remuneration Committee is chaired by Dr. Leung and comprises Dr. Hung and Prof. Tsui. The Nomination Committee is chaired by Mr. Chan and includes Dr. Hung, Dr. Leung, Prof. Tsui, and Ms. Man.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1186292093"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1186292093\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1186292093?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-31 00:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186292093","market":"us","top_or_hot":-1,"title":"PuraPharm Corporation Limited (1498) Announces Board Composition and Committee Roles","media":"Bulletin Express","content":"<p>PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent non-executive members.</p>\n<p>The Board is led by Chairman and Executive Director, Mr. Chan Yu Ling, Abraham. Other Executive Directors include Ms. Man Yee Wai, Viola and Dr. Tsoi Kam Biu, Alvin. The non-executive directors are Mr. Leung Stephen Kwok Keung and Mr. Dong Zimeng, and the independent non-executive directors are Dr. Hung Ting On, John, Dr. Leung Lim Kin, Simon, and Prof. Tsui Lap Chee.</p>\n<p>According to the announcement, the Audit Committee is chaired by Dr. Hung and includes Dr. Leung and Prof. Tsui. The Remuneration Committee is chaired by Dr. Leung and comprises Dr. Hung and Prof. Tsui. The Nomination Committee is chaired by Mr. Chan and includes Dr. Hung, Dr. Leung, Prof. Tsui, and Ms. Man.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PuraPharm Corporation Limited (1498) Announces Board Composition and Committee Roles</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPuraPharm Corporation Limited (1498) Announces Board Composition and Committee Roles\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-31 00:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent non-executive members.</p>\n<p>The Board is led by Chairman and Executive Director, Mr. Chan Yu Ling, Abraham. Other Executive Directors include Ms. Man Yee Wai, Viola and Dr. Tsoi Kam Biu, Alvin. The non-executive directors are Mr. Leung Stephen Kwok Keung and Mr. Dong Zimeng, and the independent non-executive directors are Dr. Hung Ting On, John, Dr. Leung Lim Kin, Simon, and Prof. Tsui Lap Chee.</p>\n<p>According to the announcement, the Audit Committee is chaired by Dr. Hung and includes Dr. Leung and Prof. Tsui. The Remuneration Committee is chaired by Dr. Leung and comprises Dr. Hung and Prof. Tsui. The Nomination Committee is chaired by Mr. Chan and includes Dr. Hung, Dr. Leung, Prof. Tsui, and Ms. Man.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01498","symbol_name":"培力农本方","start_time":0,"source_url":"","article_id":"1186292093","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186292093","pubTimestamp":1761840795,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01498":"培力农本方"},"translate_title":"培力控股有限公司(1498)公布董事会组成及委员会角色","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01498":1},"content_text":"PuraPharm Corporation Limited (1498) has issued an announcement dated 30 October 2025 detailing the composition of its Board of Directors, including executive, non-executive, and independent non-executive members.\nThe Board is led by Chairman and Executive Director, Mr. Chan Yu Ling, Abraham. Other Executive Directors include Ms. Man Yee Wai, Viola and Dr. Tsoi Kam Biu, Alvin. The non-executive directors are Mr. Leung Stephen Kwok Keung and Mr. Dong Zimeng, and the independent non-executive directors are Dr. Hung Ting On, John, Dr. Leung Lim Kin, Simon, and Prof. Tsui Lap Chee.\nAccording to the announcement, the Audit Committee is chaired by Dr. Hung and includes Dr. Leung and Prof. Tsui. The Remuneration Committee is chaired by Dr. Leung and comprises Dr. Hung and Prof. Tsui. The Nomination Committee is chaired by Mr. Chan and includes Dr. Hung, Dr. Leung, Prof. Tsui, and Ms. Man.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}